323 related articles for article (PubMed ID: 23267855)
1. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.
Stocker SL; Morrissey KM; Yee SW; Castro RA; Xu L; Dahlin A; Ramirez AH; Roden DM; Wilke RA; McCarty CA; Davis RL; Brett CM; Giacomini KM
Clin Pharmacol Ther; 2013 Feb; 93(2):186-94. PubMed ID: 23267855
[TBL] [Abstract][Full Text] [Related]
2. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
[TBL] [Abstract][Full Text] [Related]
3. A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin.
Christensen MM; Pedersen RS; Stage TB; Brasch-Andersen C; Nielsen F; Damkier P; Beck-Nielsen H; Brøsen K
Pharmacogenet Genomics; 2013 Oct; 23(10):526-34. PubMed ID: 23873119
[TBL] [Abstract][Full Text] [Related]
4. A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.
Choi JH; Yee SW; Ramirez AH; Morrissey KM; Jang GH; Joski PJ; Mefford JA; Hesselson SE; Schlessinger A; Jenkins G; Castro RA; Johns SJ; Stryke D; Sali A; Ferrin TE; Witte JS; Kwok PY; Roden DM; Wilke RA; McCarty CA; Davis RL; Giacomini KM
Clin Pharmacol Ther; 2011 Nov; 90(5):674-84. PubMed ID: 21956618
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics.
Chung JY; Cho SK; Kim TH; Kim KH; Jang GH; Kim CO; Park EM; Cho JY; Jang IJ; Choi JH
Pharmacogenet Genomics; 2013 Jul; 23(7):365-73. PubMed ID: 23652408
[TBL] [Abstract][Full Text] [Related]
6. Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis.
Toyama K; Yonezawa A; Masuda S; Osawa R; Hosokawa M; Fujimoto S; Inagaki N; Inui K; Katsura T
Br J Pharmacol; 2012 Jun; 166(3):1183-91. PubMed ID: 22242910
[TBL] [Abstract][Full Text] [Related]
7. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
Cho SK; Chung JY
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients.
Toyama K; Yonezawa A; Tsuda M; Masuda S; Yano I; Terada T; Osawa R; Katsura T; Hosokawa M; Fujimoto S; Inagaki N; Inui K
Pharmacogenet Genomics; 2010 Feb; 20(2):135-8. PubMed ID: 20016398
[TBL] [Abstract][Full Text] [Related]
9. Disposition of metformin: variability due to polymorphisms of organic cation transporters.
Zolk O
Ann Med; 2012 Mar; 44(2):119-29. PubMed ID: 21366511
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
[TBL] [Abstract][Full Text] [Related]
11. SLC47A1 gene rs2289669 G>A variants enhance the glucose-lowering effect of metformin via delaying its excretion in Chinese type 2 diabetes patients.
He R; Zhang D; Lu W; Zheng T; Wan L; Liu F; Jia W
Diabetes Res Clin Pract; 2015 Jul; 109(1):57-63. PubMed ID: 26004431
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of metformin.
Graham GG; Punt J; Arora M; Day RO; Doogue MP; Duong JK; Furlong TJ; Greenfield JR; Greenup LC; Kirkpatrick CM; Ray JE; Timmins P; Williams KM
Clin Pharmacokinet; 2011 Feb; 50(2):81-98. PubMed ID: 21241070
[TBL] [Abstract][Full Text] [Related]
13. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
Shibata M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
Eur J Clin Pharmacol; 2020 Aug; 76(8):1135-1141. PubMed ID: 32472157
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy Increases the Renal Secretion of N
Bergagnini-Kolev MC; Hebert MF; Easterling TR; Lin YS
Drug Metab Dispos; 2017 Mar; 45(3):325-329. PubMed ID: 28069720
[TBL] [Abstract][Full Text] [Related]
15. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
Müller F; König J; Hoier E; Mandery K; Fromm MF
Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism of organic cation transporter 2 improves glucose-lowering effect of metformin via influencing its pharmacokinetics in Chinese type 2 diabetic patients.
Hou W; Zhang D; Lu W; Zheng T; Wan L; Li Q; Bao Y; Liu F; Jia W
Mol Diagn Ther; 2015 Feb; 19(1):25-33. PubMed ID: 25573751
[TBL] [Abstract][Full Text] [Related]
17. MATE2 Expression Is Associated with Cancer Cell Response to Metformin.
Chowdhury S; Yung E; Pintilie M; Muaddi H; Chaib S; Yeung M; Fusciello M; Sykes J; Pitcher B; Hagenkort A; McKee T; Vellanki R; Chen E; Bristow RG; Wouters BG; Koritzinsky M
PLoS One; 2016; 11(12):e0165214. PubMed ID: 27959931
[TBL] [Abstract][Full Text] [Related]
18. The L125F MATE1 variant enriched in populations of Amerindian origin is associated with increased plasma levels of metformin and lactate.
Morales-Rivera MI; Alemón-Medina R; Martínez-Hernández A; Gómez-Garduño J; Mirzaeicheshmeh E; Altamirano-Bustamante NF; Ilizaliturri-Flores I; Mendoza-Caamal EC; Pérez-Guillé MG; García-Álvarez R; Contreras-Cubas C; Centeno-Cruz F; Revilla-Monsalve C; García-Ortiz H; Barajas-Olmos F; Orozco L
Biomed Pharmacother; 2021 Oct; 142():112009. PubMed ID: 34388523
[TBL] [Abstract][Full Text] [Related]
19. Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity.
Kajiwara M; Terada T; Ogasawara K; Iwano J; Katsura T; Fukatsu A; Doi T; Inui K
J Hum Genet; 2009 Jan; 54(1):40-6. PubMed ID: 19158817
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
